Zosano Pharma Corp — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$785.0K

Net Income/Loss (FY2021)

-$29.9M

Total Assets (FY2021)

$48.4M

Total Equity (FY2021)

$33.0M

Cash Flows from Operating Activities (FY2021)

-$27.6M

Source: Zosano Pharma Corp 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.